Patient & Site Solutions Center
One of the most difficult tasks of conducting a clinical trial is the study startup process. That process includes a feasibility study to determine if there are sufficient patients to meet established inclusion and exclusion criteria, site selection, and patient recruitment.
Research has shown that as many as 85 percent of trials fail to meet enrollment timelines and 80 percent fail to finish on time. Additionally, 50 percent of sites selected to participate in studies recruit one or no patients.
Patient recruitment firms and technologies are available to help sponsor companies locate patients for studies. Technology tools such as eDiaries, text reminders, and remote monitoring tools can ease the burden on patients and increase retention rates. Additionally, there are technology tools that notify sponsor companies if and when a patient takes their trial medication. AI and machine learning solutions are also available to mine EHRs and EMRs to locate patients meeting inclusion/exclusion criteria, or to search sites to determine which ones are best suited for a trial.
How can we help?
Looking for help working with Patients or Sites? If you're searching for information or a supplier, let Clinical Leader lend you a hand.
Catalyst Clinical Research
Catalyst Clinical Research is a clinical development organization providing highly customizable solutions to the global biopharmaceutical industry. Built from more than two decades of listening to their customers, devising customer-centric solutions and helping them breakthrough with clinical development programs surrounded by therapeutically aligned teams of experts.
Ciox Real World Data
Utilizing its DataFit Platform™, the Ciox Real World Data division (Ciox RWD) securely and consistently curates disparate data sets to enable researchers to access valuable clinical information that may otherwise be hidden in or across different parts of workflow systems that house medical records. The Ciox DataFit Platform™ utilizes clinical rules-based medical concept translation with unstructured data sets to build highly structured clinical data that can be used by researchers to advance care for patients.
Clinical Ink, a global clinical technology company, offers data certainty from source to submission. Our Lumenis eSource clinical technology and configurable direct data capture, eCOA, ePRO, and eConsent modules — a suite of solutions for capturing and integrating electronic data from sites, clinicians, and patients at its source — naturally enhance your clinical trial workflow by reducing manual labor, providing anytime, anywhere data access, and saving resources as your trials progress.
Cognizant’s Life Sciences business unit partners with biopharmaceutical and med-tech companies to develop strategies and apply solutions to healthcare challenges across the value chain. Our services and products, including the Cognizant® Shared Investigator Platform (SIP), are digitizing interactions between sponsors and investigators across every phase, helping the industry subtract time from clinical development and add it to patient lives.
Complion’s mission is to transform the way clinical trial documentation is maintained and shared. By re-engineering cumbersome compliance processes, we seek to unleash medical innovators to better focus on advancements that improve patient outcomes, and enhance the reputations of institutions and investigators.
Complion provides a cloud-based eRegulatory platform that improves efficiency, compliance and transparency for Research Sites, Sponsors, and CROs. We are continuously improving our platform and processes in response to our clients’ needs.
Florence accelerates clinical research with innovative solutions to streamline clinical trial site workflows and remote connect sponsors, CROs, and sites for access, monitoring, management, and SDR/V. The Florence platform is the industry standard with more than 7,200 research sites in 27 countries, sponsors and CROs collaborating on its network.
Greenphire is the leader in global clinical trial payment automation. Greenphire’s best-in-class solutions optimize clinical trial performance by streamlining payment workflows from sponsors and CROs to sites and participants. Greenphire’s ClinCard, eClinicalGPS and ConneX solutions easily handle any type of trial design and complexity, resulting in more accurate and compliant payments and travel globally for both sites and participants.
inSeption distinguishes people as the most impactful variable in the outsourcing equation. Our path-breaking model attracts biopharma companies who demand a partner that shares in their drive to conduct impeccable development and will provide quality and dependable clinical solutions. We offer full outsourcing, consulting services, and functional service provider (FSP) solutions.
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and contract research services to the life sciences industry. IQVIA applies human data science — leveraging the analytic rigor and clarity of data science to the ever-expanding scope of human science — to enable companies to reimagine and develop new approaches to clinical development and commercialization, speed innovation and accelerate improvements in healthcare outcomes.
Medidata is leading the digital transformation of life sciences, creating hope for millions of patients. Medidata helps generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostic companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. More than one million registered users across 1,400 customers and partners access the world's most-used platform for clinical development, commercial, and real-world data.
Oracle Health Sciences
As a leader in Life Sciences cloud technology, Oracle Health Sciences’ Clinical One and Safety One are trusted globally by professionals in both large and emerging companies engaged in clinical research and pharmacovigilance. With over 20 years’ experience, Oracle Health Sciences is committed to supporting clinical development, delivering innovation to accelerate advancements, and empowering the Life Sciences industry to improve patient outcomes.
Parexel is in the business of improving the world’s health. We do this by providing a suite of biopharmaceutical services that help clients across the globe transform scientific discoveries into new treatments. From clinical trials to regulatory, consulting, and market access, our therapeutic, technical, and functional ability is underpinned by a deep conviction in what we do.
Premier Research recognizes that when an emerging biotech is built around a single asset, focus and flexibility are critical to success. And, since many of our customers require additional infrastructure, we fill in resourcing gaps to help their product reach the patient faster. We are a mid-size CRO and offer strategies that are customized for each program, with tailored processes designed to meet highly specific needs.
Rho, a privately held CRO located in RTP, NC, provides clinical research services across the entire drug development process. Since 1984, Rho has been a trusted partner to the industry’s leading pharmaceutical, biotechnology, medical device companies, and academic and government organizations. Our commitment to excellence, innovative technologies, and therapeutic expertise accelerate time to market, maximize returns on investment, and lead to an exceptional customer experience.
United BioSource - UBC
United BioSource LLC (UBC) is a leading provider of pharmaceutical support services, partnering with life science companies to make medicine and medical products safer and more accessible. UBC is well known for our expertise in generating authoritative, real-world evidence of product effectiveness, safety, and value to assist healthcare decisions and enhance patient care.
Worldwide Clinical Trials
Founded by physicians committed to advancing medical science, Worldwide is out to change how the world experiences CROs – in the best possible way. From early phase and bioanalytical sciences through late phase, post-approval and real-world evidence, we provide world-class, full-service drug development services across a range of therapeutic areas, including central nervous system, cardiovascular, metabolic, general medicine, oncology and rare diseases. We never compromise on science or safety. We’re never satisfied with the status quo. We’re the Cure for the Common CRO.